Related Experiment Video
Updated: Jun 17, 2026
06:37
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Cytokines as targets for anti-inflammatory agents
1University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA. lwm5@pitt.edu
Annals of the New York Academy of Sciences
|January 16, 2010
Summary
Tumor necrosis factor (TNF) inhibitors have transformed rheumatoid arthritis (RA) treatment, offering significant benefits. Ongoing research focuses on predicting patient response and managing potential opportunistic infections associated with these therapies.
Area of Science:
- Immunology and Rheumatology
- Pharmacology and Therapeutics
Background:
- Tumor necrosis factor (TNF) plays a critical role in rheumatoid arthritis (RA) pathogenesis.
- Anti-TNF therapies, including monoclonal antibodies and receptor fusion proteins, have shown remarkable clinical benefits in RA patients.
- Five anti-TNF agents are currently approved for RA treatment.
Purpose of the Study:
- To identify which RA patients achieve meaningful clinical responses to anti-TNF monotherapy or combination therapy.
- To investigate potential adverse events associated with anti-TNF therapies, particularly opportunistic infections.
Main Methods:
- Clinical trials and observational studies evaluating anti-TNF agents in RA patients.
- Analysis of patient outcomes using measures like ACR 20 and DAS scores.
- Monitoring and assessment of adverse events, focusing on infection rates.
Main Results:
- Anti-TNF therapies have significantly improved outcomes for RA patients, revolutionizing treatment.
- Predicting individual patient response to anti-TNF agents remains an active area of research.
- An increased risk of opportunistic infections is the most clearly linked adverse event.
Conclusions:
- Anti-TNF therapies represent a major advancement in managing RA, a condition with significant morbidity and mortality.
- Further research is needed to optimize patient selection and safety monitoring for anti-TNF treatments.
More Related Videos
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...